Cancer Fund Impact Investments
CANCER FUND is pleased to announce its investment in NXgenPort, an early-stage company developing technology to advance remote monitoring of cancer patients’ health. This marks Cancer Fund I’s seventh investment and reflects its dedication to fostering impactful innovations in oncology.... Read More →
InkSpace Imaging Submits FDA 510(k) for 1.5T 24-channel Body Array for Siemens Healthineers MRI Scanners
Pleasanton, California –November 29, 2024 – InkSpace Imaging, a leader in MRI coil innovation, has announced the submission for FDA clearance of its next-generation body array for Siemens Healthineers Magnetom 1.5 Tesla MRI scanners. The 1.5T body array is a... Read More →
Gravitas Medical, Inc. Announces SECOND FDA Clearance for its Entarik System; Neonatal Patients to Benefit from Enteral Nutrition Innovation
Gravitas Medical received NEONATAL FDA 510(k) clearance for the Entarik system, which aids in the placement of feeding tubes and continuously monitors feeding tube position, gastric and esophageal temperature, and gastrointestinal impedance and reflux. BERKELEY, Calif., Nov. 27, 2024 /PRNewswire-PRWeb/... Read More →
Acorai closes $4.5M investment from the European Innovation Council (EIC) Fund
Acorai, a Swedish developer and manufacturer of innovative devices for heart failure management, announced the closing of a $4.5M investment from the EIC Fund, Taiwan Medical University, and private investors. The capital will be used to complete Acorai’s clinical studies... Read More →
How AI can make cow IVF smarter and more sustainable — Dr. Cara Wells, EmGenisys
Ever wondered how modern breeding techniques are making cattle farming more sustainable? This week, we dive deep into the world of cattle IVF with Dr. Cara Wells, a reproductive physiologist and founder of EmGenisys. She explains how advanced reproductive technologies... Read More →
Vuno secures second 510(k) and more briefs
Vuno receives second 510(k) South Korean medical AI company Vuno has obtained a 510(k) clearance from the United States Food and Drug Administration for its chest X-ray analysis AI software. The VunoMed Chest X-ray Triage quickly screens for pneumothorax and... Read More →
Indapta Therapeutics applies TIMING to elucidate the mechanisms of enhanced ADCC featuring CellChorus®
HOUSTON, Texas — November 20, 2024. Indapta Therapeutics (Houston, TX & Seattle, WA) presented data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting featuring data from the CellChorus® Time-lapse Imaging Microscopy In Nanowell Grids™ (TIMING™) platform demonstrating that... Read More →
Mentorship Program Sparks U.S.-Latin American Doctor’s Shift to Medtech featuring Samay
Maria Artunduaga’s grandmother never smoked. However, like many members of her generation, she was exposed to second-hand cigarette smoke much of her life. When she developed chronic obstructive pulmonary disease (COPD), lung monitoring technologies were inadequate. Maria’s grandmother lived until... Read More →
Enrich TROVO Recognized With BioTech Breakthrough’s “Cell Sorting Product of the Year”
Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology Industries LOS ANGELES, Nov. 19, 2024 (GLOBE NEWSWIRE) — BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products... Read More →
Zenflow Announces $24 Million Financing Round to Fund FDA Filing & Commercial Preparation
Round to Support PMA Submission of Minimally Invasive Treatment for Enlarged Prostate Symptoms SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) — Zenflow, Inc., a medical device company developing a minimally invasive treatment for urinary obstruction caused by enlarged... Read More →